Denka Company (4061) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
13 May, 2026Executive summary
Operating income for FY2025 rose to ¥26.2B (+¥11.8B YoY), driven by semiconductor and power infrastructure demand, and DPE production suspension effects.
Net income surged to ¥15.7B (+¥28.0B YoY), reversing a prior year loss, aided by gains from strategic shareholdings and land sales, offsetting DPE-related losses.
FY2026 guidance incorporates a ¥5.0B negative impact from Middle East supply disruptions, with operating income forecast at ¥30.0B (+¥3.8B YoY).
Dividend maintained at ¥100/share, targeting a 50% total return ratio over the management plan period.
Comprehensive income reached ¥19.1B, compared to a loss of ¥7.1B the previous year.
Financial highlights
FY2025 sales: ¥384.2B (down 4.0% YoY); operating margin improved to 6.8% (+3.2pp YoY).
Ordinary income: ¥19.3B (+¥11.7B YoY); ROE: 5.2%.
Extraordinary gains: ¥12.6B from shareholdings, ¥8.2B from land sale; extraordinary losses: ¥21.1B (mainly DPE-related).
Gross profit increased to ¥94.3B from ¥84.6B YoY.
Annual dividend per share was ¥100.00, with a payout ratio of 54.9%.
Outlook and guidance
FY2026/FY2027 sales forecast: ¥450.0B (+¥65.8B YoY); operating income: ¥30.0B (+¥3.8B YoY); net income: ¥16.0B (+¥0.3B YoY).
Assumes raw material procurement disruptions in H1, normalizing from October, with high raw material prices persisting.
Dividend forecast maintained at ¥100.00 per share.
Middle East disruptions expected to impact acetylene black and polymer solutions volumes.
Latest events from Denka Company
- Net income surged on asset sales despite lower sales, operating income, and DPE suspension.4061
Q1 202617 Mar 2026 - Mission 2030 Phase 2 targets record earnings, portfolio transformation, and sustainability.4061
Investor presentation27 Feb 2026 - Operating and net income surged despite lower sales, led by semiconductors and cost controls.4061
Q3 20266 Feb 2026 - Net sales rose but profits fell; full-year growth and stable dividends are forecast.4061
Q2 20257 Jan 2026 - Profits rose in 1H FY2025, with stable profit guidance and DPE losses offset by asset sales.4061
Q2 202610 Nov 2025 - Strong profit growth continues, but US regulatory risks for chloroprene rubber remain.4061
Q1 202513 Jun 2025 - Profit rebound is forecast after a net loss from extraordinary DPE-related losses.4061
Q4 20256 Jun 2025 - Sales up, profits down; forecasts and dividend unchanged amid regulatory risks.4061
Q3 20255 Jun 2025